Medical Advocates
RDEA806
 
Main Page

New and Noteworthy
Journal Data
 






 
ARV Investigational  Drugs Main New/Noteworthy Home Page      
Last Update:  March 11, 2015
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
 
May  2010
 
Journal Abstracts , Papers, and Commentaries
 
 
A Phase 2a randomized controlled trial of the short term activity, safety and
pharmacokinetics of a novel NNRTI, RDEA806 in HIV-1 positive,
antiretroviral-naive subjects.
 Moyle G, Boffito M, Stoehr A, et al
Antimicrob Agents Chemother. 2010 May 24.

 

 
   
   

ARV Investigational  Drugs Main New/Noteworthy Home Page      

RDEA806